Cambrex Corporation announced three senior appointments to further support the company’s strategy to create the Contract Development and Manufacturing Organization (CDMO) of choice for small molecules within the pharmaceutical industry. Bruno Biscaro has been appointed President, Drug Products. In this new role, he will have global responsibility for the company’s drug product business. Mr. Biscaro has over 30 years’ experience in pharmaceutical leadership and joins Cambrex from Famar where he was President, North America. Prior to this role, he was President of Accucaps Industries and has also held numerous leadership positions for GlaxoSmithKline including his last mandate as Regional Director, Global Supply Network Program for the North American Supply Executive Team. Joe Nettleton has been appointed as President, Drug Substance with responsibility for operations at the Charles City, Iowa; Karlskoga, Sweden; Wiesbaden, Germany; and Tallinn, Estonia facilities. Mr. Nettleton formally held the position of VP, US Operations and has been with Cambrex for 28 years. Simon Edwards has been appointed as President, CDMO Sales & Marketing. He will provide customers with a single point of contact for the company’s CDMO services, as well as drive commercial activity and brand recognition for Cambrex as the leading small molecule company. All positions report to Shawn Cavanagh, EVP and Chief Operating Officer.